Kirkland & Ellis represented Warburg Pincus in the transaction. Warburg Pincus, a leading global growth investor, announced the formation of its inaugural capital solutions fund, Warburg...
Warburg Pincus’ Inaugural $4 Billion Capital Solutions Fund
Palomar Health’s Data Privacy Class Action
Holland & Knight successfully represented Palomar Health in the case. Palomar Health secured a dismissal of the class action lawsuit involving its alleged misuse of online...
Neo Medical SA’s Series B and $68 Million Equity Investment
Wilson Sonsini Goodrich & Rosati advised Neo Medical on U.S. aspects of the financing. Neo Medical SA (Neo), a Swiss technology company specializing in spine surgery,...
Falfurrias Management Partners’ Investment in Snak King
K&L Gates advised Falfurrias, while Sheppard Mullin advised Snak King in the transaction. Snak King, one of the largest producers of co-manufactured and private-label salty snacks...
Organon’s Acquisition of Dermavant from Roivant
Freshfields advised Roivant in sale of Dermavant to Organon. Organon & Co. has announced the acquisition of Dermavant Sciences Ltd., a subsidiary of Roivant Sciences Ltd.,...
BioCardia’s $7.2 Million Common Stock Offering
Wilson Sonsini Goodrich & Rosati advised BioCardia, while Sullivan & Worcester advised A.G.P./Alliance Global Partners on the offering. BioCardia, Inc. (Nasdaq: BCDA) completed its $7.2 million...
Uranium Royalty Corp’s Renewal of its At-the-Market Equity Program for US$39m
Gowling WLG advised the Agents. Uranium Royalty Corp. (NASDAQ: UROY) (TSX: URC) (the “Company”) has renewed its at-the-market equity program (“ATM Program”), enabling the distribution of...
Zenas BioPharma’s $225 Million IPO
Ropes & Gray represented Zenas BioPharma in the transaction, and Cooley represented the underwriters. Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company, announced...
Centrais Eletricas Brasileiras S.A. (Eletrobras)’s $750 Million Bond Issuance
Clifford Chance advised Centrais Elétricas Brasileiras S.A. (Eletrobras) on the deal. Centrais Elétricas Brasileiras S.A. – Eletrobras has successfully issued a $750 million 6.500% Notes due...
Switch Bioworks’ $17 Million Series Seed Financing
Fenwick & West represented Switch Bioworks in the transaction. Switch Bioworks, a biotechnology company, announced raising $17 million in series seed financing. The round was led...
Corporacion Andina de Fomento (CAF)’s $1 Billion Notes Offering
Clifford Chance advised the underwriters of the issuance. Corporación Andina de Fomento (CAF), a Latin American development bank, completed a US$1 billion 4.125% notes offering due...
Circle Pharma’s $90 Million Series D Financing Round
Wilson Sonsini Goodrich & Rosati represented Circle Pharma in the transaction. Circle Pharma, a clinical-stage biopharmaceutical company, announced the closing of a $90 million Series D...